Organon & Co.
For the period ended Mar 31, 2026. Filed May 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 4, 2026
OGN$13.87+0.6%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Number | Description | ||
|---|---|---|---|
| 2.1 | — | Agreement and Plan of Merger, dated as of April 26, 2026, by and among Organon & Co., Sun Pharmaceutical Holdings USA, Inc., Sun Pharma America, Inc. and, solely for the purposes of certain Covered Provisions of the Merger Agreement (as defined therein), Sun Pharmaceutical Industries Limited, Sun Pharma Canada Inc. and Sun Pharma (Netherlands) B.V. (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on April 27, 2026). | |
| *+10.1 | — | Form of Global Terms for 2026 Performance Share Unit Award Under the Organon & Co. 2021 Incentive Stock Plan. | |
| *+10.2 | — | Form of Global Terms for 2026 Restricted Stock Unit Grants Under the Organon & Co. 2021 Incentive Stock. | |
| *+10.3 | — | Form of Global Terms for 2026 Performance Share Unit Award Under the Organon & Co. 2021 Incentive Stock Plan (Interim Chief Executive Officer). | |
| *+10.4 | — | Form of Global Terms for 2026 Restricted Stock Unit Grants Under the Organon & Co. 2021 Incentive Stock Plan (Interim Chief Executive Officer). | |
| *31.1 | — | Certification of Principal Executive Officer (CEO) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| *31.2 | — | Certification of Principal Financial Officer (CFO) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| **32.1 | — | Section 1350 Certification of Principal Executive Officer (CEO) pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| **32.2 | — | Section 1350 Certification of Principal Financial Officer (CFO) pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| 101.INS | — | XBRL Instance Document - The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document. | |
| 101.SCH | — | XBRL Taxonomy Extension Schema Document. | |
| 101.CAL | — | XBRL Taxonomy Extension Calculation Linkbase Document. | |
| 101.DEF | — | XBRL Taxonomy Extension Definition Linkbase Document. | |
| 101.LAB | — | XBRL Taxonomy Extension Label Linkbase Document. | |
| 101.PRE | — | XBRL Taxonomy Extension Presentation Linkbase Document. | |
| 104 | — | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | |
| + · Management contract or compensatory plan or arrangement. | |||
| * · Filed herewith. | |||
| ** · Furnished herewith. | |||
-38-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.